Concepedia

Grennady Wirjanata

GW

Statistics

Publications

26

Citations

2.3K

H-Index

20

Active since

2012

Affiliations

Menzies School of Health Research(Current)

Charles Darwin University

Eijkman Institute for Molecular Biology

University of Oxford

Medicines for Malaria Venture

Grennady Wirjanata is an author at Menzies School of Health Research specializing in plasmodium falciparum, malaria, and pharmacology.

ORCID

Publications per year

2012–2024

26

Publications

26

A novel multiple-stage antimalarial agent that inhibits protein synthesis

Beatriz Baragaña, Irene Hallyburton, Neil R. Norcross et al. · Nature · 2015 · 465 citations · Full text

, , +14

Quinolone-3-Diarylethers: A New Class of Antimalarial Drug

Aaron Nilsen, Alexis N. LaCrue, Karen L. White et al. · Science Translational Medicine · 2013 · 302 citations

, , +12

Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay

Jerzy M. Dziekan, Han Yu, Dan Chen et al. · Science Translational Medicine · 2019 · 231 citations

, , +16

KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission

Kelli Kuhen, Arnab K. Chatterjee, Matthias Rottmann et al. · Antimicrobial Agents and Chemotherapy · 2014 · 158 citations · Full text

, , +17

Cellular thermal shift assay for the identification of drug–target interactions in the Plasmodium falciparum proteome

Jerzy M. Dziekan, Grennady Wirjanata, Lingyun Dai et al. · Nature Protocols · 2020 · 140 citations

, , +15

1–5 of 26